Canada markets close in 5 hours 10 minutes

NeonMind Biosciences Inc. (NEON.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.08000.0000 (0.00%)
As of 02:52PM EDT. Market open.

NeonMind Biosciences Inc.

295 Robinson Street
Suite 100
Oakville, ON L6J 1G7
Canada

https://www.neonmindbiosciences.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Ms. Penny Olga White B.A., BA, L.L.B., LLBCo-Founder, CEO & Director10kN/A1972
Mr. Jeff B. Smith B.A., M.B.A.Co- FounderN/AN/AN/A
Mr. Yu Cai Huang CPA, CGA, M.B.A.Chief Financial OfficerN/AN/A1969
Ms. Tamara MelckChief Operating OfficerN/AN/AN/A
Mr. Ernie HoVP of Corp. Devel.N/AN/AN/A
Mr. Trevor MillarAdvisorN/AN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

NeonMind Biosciences Inc. engages in the discovery, development, and commercialization of medicinal and psychedelic mushrooms for mental illnesses. It is developing psilocybin-based products comprising mushroom-infused products and other mushroom-infused products to treat weight loss and management. The company was formerly known as Flourish Mushroom Labs Inc. and changed its name to NeonMind Biosciences Inc. in April 2020. NeonMind Biosciences Inc. was incorporated in 2019 and is based in Oakville, Canada. NeonMind Biosciences Inc. is a subsidiary of The Yield Growth Corp.

Corporate Governance

NeonMind Biosciences Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.